This is a bit concerning. Looks like multiple requests from the SEC for follow-up material and no response back. How the heck is NGIO supposed to get uplisted if the SEC can't even get a response back from Joe?
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links
